|
|
| | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid Basic information |
| Product Name: | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid | | Synonyms: | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-(1,3)-thiazeto;6-Fluoro-1-Methyl-4-oxo-7-;6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxy;6-Fluoro-1-Methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;6-fluoro-1-Methyl-4-oxo- 7-(1-piperazinyl)-4H-(1,3) S,N-containing heterocyclic bi- (3,2-a) quinoline-3-carboxylic acid;PL-11;6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic;PRULIFLOXACIN INTERMEDIATE 3 | | CAS: | 112984-60-8 | | MF: | C16H16FN3O3S | | MW: | 349.38 | | EINECS: | 601-220-5 | | Product Categories: | PRULIFLOXACIN;(intermediate of prulifloxacin);Aromatics;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;API intermediates;Other Products;Pharmaceuticals;Sulfur & Selenium Compounds;Isotope Labelled Compounds | | Mol File: | 112984-60-8.mol | ![6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid Structure](CAS/GIF/112984-60-8.gif) |
| | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid Chemical Properties |
| Melting point | 215-218 °C (decomp) | | Boiling point | 577.0±50.0 °C(Predicted) | | density | 1.58±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO (Sparingly), Methanol (Slightly) | | form | Solid | | pka | 5.85±0.40(Predicted) | | color | Pale Yellow to Yellow | | InChI | 1S/C16H16FN3O3S/c1-8-20-11-7-12(19-4-2-18-3-5-19)10(17)6-9(11)14(21)13(16(22)23)15(20)24-8/h6-8,18H,2-5H2,1H3,(H,22,23) | | InChIKey | SUXQDLLXIBLQHW-UHFFFAOYSA-N | | SMILES | Fc1cc2c(cc1N4CCNCC4)N3C(SC3=C(C2=O)C(=O)O)C | | CAS DataBase Reference | 112984-60-8(CAS DataBase Reference) |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Lact. Skin Irrit. 2 STOT RE 2 |
| | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid Usage And Synthesis |
| Chemical Properties | Yellow Solid | | Uses | A labelled metabolite of Prulifloxacin (P838885). Ulifloxacin is a new quinolone antibiotic and it is effective against pneumonia. | | Uses | A metabolite of Prulifloxacin (P838885). Ulifloxacin is a new quinolone antibiotic and it is effective against pneumonia. | | Definition | ChEBI: Ulifloxacin is a member of quinolines. | | Biological Activity | Ulifloxacin is an orally available, broad-spectrum fluoroquinolone antibacterial agent. Ulifloxacin is an active metabolite of Prulifloxacin. It potently inhibits bacterial DNA gyrase and topoisomerase IV. | | Synthesis | The general procedure for the synthesis of 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazolo[3,2-a]quinoline-3-carboxylic acid from ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1,4-dihydro-[1,3]thiazolo[3,2-a]quinoline-3-carboxylate was as follows:
1. ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazolo[3,2-a]quinoline-3-carboxylate (100 g, 0.265 mol) was dissolved in water (600 ml) at 25-30 °C with stirring.
2. potassium hydroxide solution (50 g of potassium hydroxide flakes dissolved in 200 ml of water) was slowly added to this solution.
3. the reaction mixture is heated to 80-85°C and stirred at this temperature for 1 hour.
4. After completion of the reaction, the reaction mixture was cooled down to 25-30 °C. The reaction mixture was then cooled down to 25-30 °C.
5. The pH of the reaction mixture was adjusted to 6.5-7.0 using a 1:1 aqueous solution of acetic acid.
6. The reaction mixture was stirred at room temperature for 1 hour to allow the product to fully precipitate.
7. The precipitated solid was collected by filtration and washed with distilled water (2 x 100 mL).
8. The solid was slurried in methanol (300 ml) at 25-30 °C for 1 h. The reaction mixture was stirred for 1 h at room temperature.
9. After filtration, the solid was washed with methanol (2 x 50 ml).
10. The product was dried under vacuum at 70-75 °C to afford 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid (90 g, 97% yield, 96% HPLC purity). | | References | [1] Patent: WO2012/1357, 2012, A1. Location in patent: Page/Page column 22 [2] Patent: CN103113392, 2016, B. Location in patent: Paragraph 0024; 0037; 0038; 0039 [3] Patent: CN107383069, 2017, A. Location in patent: Paragraph 0063; 0064 [4] Journal of Medicinal Chemistry, 1992, vol. 35, # 25, p. 4727 - 4738 [5] Patent: WO2009/93268, 2009, A1. Location in patent: Page/Page column 15 |
| | 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid Preparation Products And Raw materials |
|